Baxter said in a statement Wednesday that its goal is to return to 90% to 100% allocation of certain IV solutions by the end ...

Baxter Jan. 28 announced that IV solutions production has been restarted on all manufacturing lines at its North Carolina ...

Read about the sudden retirement of Baxter International's CEO José Almeida and the company's recovery efforts after a large manufacturing plant was damaged.

Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...

Currently, Baxter has increased allocation levels of its highest demand IV fluids for direct customers from 40 percent to 60 percent, and for distributors from 10 percent to 60 percent ...

After months of work to clean and restore the facility, Baxter late last year released the first product – 1-liter IV solutions – that was manufactured at the site since the flooding occurred.

Infusion Pumps In our opinion ... Injectable Therapies Also in its legacy product set, Baxter sells a variety of IV solutions, nutritional products, and generic pharmaceuticals.

Baxter International has increased allocations for two U.S. IV solutions to 100% following the disruption caused by Hurricane Helene at its North Cove, N.C., facility, according to a letter to ...

Baxter's remaining portfolio includes everything from hospital beds to infusion pumps. Almeida said Baxter ... Care index is up 1% from last year. IV plant comes back to life Baxter is still ...